Skip to main content Accessibility help
×
Home

Echocardiographic study of paediatric patients with mucopolysaccharidosis

  • Gabriela N. Leal (a1), Ana C. de Paula (a2), Cláudio Leone (a3) and Chong A. Kim (a2)

Abstract

Principle

Mucopolysaccharidosis is an inborn error of metabolism causing glucosaminoglycans tissue storage. Cardiovascular involvement is variable but contributes significantly towards the morbidity and mortality of the patients.

Objective

To characterise the echocardiographic abnormalities in children and adolescents with different types of mucopolysaccharidosis.

Method

Echocardiograms and medical records of 28 patients aged 2–14 years, seen from 2003 to 2005, were revised. At that time, the enzymatic replacement therapy was still not available in our institution.

Results

Echocardiographic alterations were detected in 26 patients (93%), whereas 16 (57%) had abnormal auscultation, and only 6 (21%) presented with cardiovascular complaint. Mitral valve thickening with dysfunction (regurgitation, stenosis, or double lesion) was diagnosed in 60.8%, left ventricular hypertrophy in 43% and aortic valve thickening with regurgitation in 35.8% of the patients. There was no systolic dysfunction and mild left diastolic dysfunction was shown in 21.5% of the patients. Pulmonary hypertension was present in 36% of the patients, causing the only two deaths recorded. There was a strong association between the accumulation of dermatan sulphate and the presence of mitral valve dysfunction (p = 0.0003), aortic valve dysfunction (p = 0.006), and pulmonary hypertension (p = 0.006). Among individuals with two or more examinations, 82% had a worsening evolution.

Conclusions

Echocardiographic alterations in children with Mucopolysaccharidosis are frequent and have a progressive character. Left valve lesions, ventricular hypertrophy, and pulmonary hypertension were the most common findings and there was an association between the accumulation of dermatan sulphate and cardiovascular involvement. Unlike in adults, pulmonary hypertension was the main cause of death, not left ventricle systolic dysfunction.

Copyright

Corresponding author

Correspondence to: Dr G. N. Leal, Rua Pageú 100, ap 142, Chácara Inglesa, Zip code: 04139 000, São Paulo, SP, Brasil. Tel and Fax: +55 11 2578 76 73; E-mail: gnleal@gmail.com

References

Hide All
1. Aumailley, M, Gayraud, B. Structure and biological activity of the extracellular matrix. Mol Med 1998; 76: 253265.
2. Guertl, B, Noehammer, C, Hoefler, G. Metabolic cardiomyopathies. Int J Exp Pathol 2001; 81: 349372.
3. Muenzer, J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004; 144: 2734.
4. Robins, S, Kumar, V, Cotran, R. Genetical disorders. In: Robins S, Kumar V, Cotran R (eds). Pathologic Basis of Disease, 4th edn. W.B. Saunders Company, Philadelphia, 1989, pp 149151.
5. Kettles, DI, Sheppard, , Liebmann, RD, Davidson, C. Left ventricular aneurysm, aortic valve disease and coronary narrowing in a patient with Hunter’s syndrome. Cardiovasc Pathol 2002; 11: 9496.
6. Hishitani, T, Wakita, S, Isoda, T, et al. Sudden death in Hunter Syndrome caused by complete atrioventricular block. J Pediatr 2000; 136: 268269.
7. Dangel, JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders – clinical and echocardiographic findings in 64 patients. Eur J Pediatr 1998; 157: 534538.
8. Rigante, D, Segni, G. Cardiac structural involvement in mucopolysaccharidoses. Cardiology 2002; 98: 1820.
9. Braulin, EA, Berry, JM, Whitley, CB. Cardiac findings after enzyme replacement therapy for Mucopolysaccharidosis Type I. Am J Cardiol 2006; 98: 416418.
10. Dubois, D, Dubois, EF. A formula to estimate the aproximate surface area if height and weight are known. Arch Intern Med 1916; 17: 863871.
11. Kampmann, C, Wiethoff, CM, Wenzel, A, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000; 83: 667672.
12. O’Leary, PW, Durongpisitkul, K, Cordes, TM, et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of ventricular end diastolic pressure. Mayo Clin Proc 1998; 73: 616628.
13. Carvalho, ACC, Almeida, DR, Lopes, AA. Diagnóstico, Avaliação e Terapêutica da Hipertensão Pulmonar. In: Lopes AA (ed.). Diretrizes da Sociedade Brasileira de Cardiologia, 2005.
14. Zoghbi, WA, Sarano, ME, Foster, E, et al. Recommendation for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777802.
15. Riggs, TW, Lapin, GD, Paul, MH, Muster, AJ, Berry, TE. Measurement of mitral valve orifice area in infants and children by two-dimensional echocardiography. J Am Coll Cardiol 1983; 1: 873878.
16. Gross, DM, Julian, CM, Caprioli, C, Dominguez, B, Howell, R. Echocadiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol 1988; 61: 170176.
17. Mohan, UR, Hay, AA, Cleary, MA, Wraith, JE, Patel, RG. Cardiovascular changes in children with mucopolysaccharide disorders. Acta Paediatr 2002; 91: 799804.
18. Nelson, J, Shields, MD, Mulholand, HC. Cardiovascular studies in the mucopolysaccharidoses. J Med Genet 1990; 27: 94100.
19. Soliman, O, Timmermans, RGM, Nemes, A, et al. Cardiac abnormalities in adults with attenuated form of mucopolysaccharidosis type I. J Inherit Metab Dis 2007; 30: 750757.
20. Neufeld, EF, Muenzer, J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited diseases, 7th edn. McGray-Hill, New York, 1995, pp 24652494.
21. Chan, D, Li, AM, Yam, MC, Li, CK, Fok, TF. Hurler’s syndrome with cor pulmonale secondary to obstructive sleep apnoea treated by continuous positive airway pressure. J Paediatr Child Health 2003; 39: 558559.
22. Walker, RWM, Darowski, M, Morris, P, Wraith, JE. Anaesthesia and mucopolisaccharidoses. Anaesthesia 1994; 49: 10781084.
23. Butman, SM, Karl, L, Copeland, J. Combined aortic and mitral valve replacement in adult with Scheie’s disease. Chest 1989; 96: 209210.
24. Kraiem, S, Lahidheb, D, Chehaibi, N, et al. Rétrécissement mitral secondaire à un syndrome de Hurler. Arch Mal Coeur 2001; 94: 153156.
25. Shapiro, J, Strome, M, Crocker, A. Airway obstruction and sleep apnea in Hurler and Hunter syndromes. Ann Otol Rhinol Laryngol 1985; 94: 458461.
26. Pierpont, MEM, Moller, JH. Cardiac manifestations of systemic disease. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP (eds). Moss and Adams’ Heart Disease in Infants, Children, and Adolescents, 4th edn. Willians and Wilkins, Baltimore, 1989, pp 778783.
27. John, RM, Hunter, D, Swanton, RH. Echocardiographic abnormalities in type IV mucopolysaccharidoses. Arch Dis Child 1990; 65: 746749.
28. Schuldt, AJT, Hampton, TJ, Chu, V, et al. Electrocardiographic and other cardiac anomalies in β-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation. Proc Nat Acad Sci USA 2004; 101: 603608.
29. Honjo, O, Ishino, K, Kawada, M, Ohtsuki, S, Sano, S. Coarctation of the thoraco-abdominal aorta associated with Mucopolisaccharidose VII in a child. Ann Thorac Surg 2005; 80: 729731.

Keywords

Echocardiographic study of paediatric patients with mucopolysaccharidosis

  • Gabriela N. Leal (a1), Ana C. de Paula (a2), Cláudio Leone (a3) and Chong A. Kim (a2)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed